8K3K
The crystal structure of nanobody Nb4 in complex with receptor binding domain (RBD) of BA.1 Spike protein
8K3K の概要
エントリーDOI | 10.2210/pdb8k3k/pdb |
分子名称 | Spike protein S1, Nanobody Nb4 (3 entities in total) |
機能のキーワード | nanobody, receptor binding domain, sars-cov-2, complex, viral protein, viral protein-immune system complex, viral protein/immune system |
由来する生物種 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 45387.51 |
構造登録者 | |
主引用文献 | Yao, H.,Wang, H.,Zhang, Z.,Lu, Y.,Zhang, Z.,Zhang, Y.,Xiong, X.,Wang, Y.,Wang, Z.,Yang, H.,Zhao, J.,Xu, W. A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains. MedComm (2020), 4:e397-e397, 2023 Cited by PubMed Abstract: SARS-CoV-2 viruses are highly transmissible and immune evasive. It is critical to develop broad-spectrum prophylactic and therapeutic antibodies for potential future pandemics. Here, we used the phage display method to discover nanobodies (Nbs) for neutralizing SARS-CoV-2 viruses especially Omicron strains. The leading nanobody (Nb), namely, Nb4, with excellent physicochemical properties, can neutralize Delta and Omicron subtypes, including BA.1, BA.1.1 (BA.1 + R346K), BA.2, BA.5, BQ.1, and XBB.1. The crystal structure of Nb4 in complex with the receptor-binding domain (RBD) of BA.1 Spike protein reveals that Nb4 interacts with an epitope on the RBD overlapping with the receptor-binding motif, and thus competes with angiotensin-converting enzyme 2 (ACE2) binding. Nb4 is expected to be effective for neutralizing most recent Omicron variants, since the epitopes are evolutionarily conserved among them. Indeed, trivalent Nb4 interacts with the XBB1.5 Spike protein with low nM affinity and competes for ACE2 binding. Prophylactic and therapeutic experiments in mice indicated that Nb4 could reduce the Omicron virus loads in the lung. In particular, in prophylactic experiments, intranasal administration of multivalent Nb4 completely protected mice from Omicron infection. Taken together, these results demonstrated that Nb4 could serve as a potent and broad-spectrum prophylactic and therapeutic Nb for COVID-19. PubMed: 37901798DOI: 10.1002/mco2.397 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.43 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード